Nadir Creatinine in Congenital Anomalies of the Kidney and Urinary Tract (CAKUT): A Single-Center Experience.
CAKUT
ESRD
children
nadir creatinine
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
01
07
2024
revised:
28
07
2024
accepted:
30
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Congenital anomalies of the kidney and urinary tract (CAKUT) are the main cause of chronic kidney disease (CKD) requiring renal replacement therapy (RRT) in children, being the leading cause (50-70%) of end-stage renal disease (ESRD) in children and young adults. Our study aimed to assess the natural evolution of various antenatally diagnosed renal malformations and to identify potential prognostic factors to guide the therapeutic management of patients with CAKUT. We conducted a retrospective study on 205 children with CAKUT. For each patient, analyzing their medical records, we established the nadir value of serum creatinine, defined as the lowest creatinine level during the first year of life. We assessed the value of nadir creatinine as a prognostic marker in patients with CAKUT, and using an ROC curve, we also determined a threshold value of nadir creatinine that predicted progression to ESRD. The male-to-female ratio was 2.8 to 1. The mean gestational age at detection was 29.85 weeks (±6.71). A total of 36 patients (17.6%) had impaired renal function, of which 8 (3.9% of the total) progressed to ESRD. The mean nadir creatinine in patients with ESRD was 1.39 mg/dL. A nadir creatinine cut-off of 0.98 mg/dL had high sensitivity and specificity in identifying patients with progression to ESRD, with an AUC of 0.95 and a 95% confidence interval between 0.86 and 1.05 mg/dL. Our results support the value of nadir creatinine in predicting progression to ESRD, consistent with previously published data.
Sections du résumé
BACKGROUND/OBJECTIVES
OBJECTIVE
Congenital anomalies of the kidney and urinary tract (CAKUT) are the main cause of chronic kidney disease (CKD) requiring renal replacement therapy (RRT) in children, being the leading cause (50-70%) of end-stage renal disease (ESRD) in children and young adults. Our study aimed to assess the natural evolution of various antenatally diagnosed renal malformations and to identify potential prognostic factors to guide the therapeutic management of patients with CAKUT.
METHODS
METHODS
We conducted a retrospective study on 205 children with CAKUT. For each patient, analyzing their medical records, we established the nadir value of serum creatinine, defined as the lowest creatinine level during the first year of life. We assessed the value of nadir creatinine as a prognostic marker in patients with CAKUT, and using an ROC curve, we also determined a threshold value of nadir creatinine that predicted progression to ESRD.
RESULTS
RESULTS
The male-to-female ratio was 2.8 to 1. The mean gestational age at detection was 29.85 weeks (±6.71). A total of 36 patients (17.6%) had impaired renal function, of which 8 (3.9% of the total) progressed to ESRD. The mean nadir creatinine in patients with ESRD was 1.39 mg/dL. A nadir creatinine cut-off of 0.98 mg/dL had high sensitivity and specificity in identifying patients with progression to ESRD, with an AUC of 0.95 and a 95% confidence interval between 0.86 and 1.05 mg/dL.
CONCLUSIONS
CONCLUSIONS
Our results support the value of nadir creatinine in predicting progression to ESRD, consistent with previously published data.
Identifiants
pubmed: 39201862
pii: children11080928
doi: 10.3390/children11080928
pmc: PMC11352228
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Pediatr Nephrol. 2014 Dec;29(12):2403-10
pubmed: 25039018
Urol Ann. 2014 Jan;6(1):36-40
pubmed: 24669120
Pediatr Nephrol. 2022 Jun;37(6):1215-1229
pubmed: 34091754
Surgery. 2016 Jun;159(6):1638-1645
pubmed: 26962006
J Urol. 2010 Jul;184(1):265-73
pubmed: 20483150
Pediatr Nephrol. 2014 Apr;29(4):757-66
pubmed: 24500705
Fetal Pediatr Pathol. 2014 Oct-Dec;33(5-6):293-320
pubmed: 25313840
J Am Soc Nephrol. 2008 May;19(5):847-62
pubmed: 18322164
Pediatr Clin North Am. 2022 Dec;69(6):1115-1129
pubmed: 36880925
Front Pediatr. 2023 Mar 15;11:1085143
pubmed: 37009274
Nat Rev Nephrol. 2015 Dec;11(12):720-31
pubmed: 26281895
Nat Rev Urol. 2022 May;19(5):295-303
pubmed: 35136187
Nephrol Dial Transplant. 2011 Dec;26(12):3843-51
pubmed: 22121240
Arch Dis Child. 1993 Jan;68(1 Spec No):22-6
pubmed: 8439191
Pediatr Nephrol. 2023 Apr;38(4):1057-1066
pubmed: 35951131
Ital J Pediatr. 2019 Apr 18;45(1):50
pubmed: 30999930
Front Pediatr. 2019 May 14;7:182
pubmed: 31139603
Ultraschall Med. 2012 Dec;33(7):E333-E338
pubmed: 23238802
Pediatr Nephrol. 2012 Mar;27(3):497-502
pubmed: 22167562
Adv Chronic Kidney Dis. 2017 Nov;24(6):348-356
pubmed: 29229165
Clin J Am Soc Nephrol. 2020 May 7;15(5):723-731
pubmed: 32188635
J Perinatol. 2016 Nov;36(11):954-959
pubmed: 27467564
Nat Rev Nephrol. 2023 Nov;19(11):709-720
pubmed: 37524861
J Pediatr Urol. 2015 Dec;11(6):356.e1-5
pubmed: 26292912
Birth Defects Res A Clin Mol Teratol. 2016 Mar;106(3):185-93
pubmed: 26833755
Pediatr Nephrol. 2012 Jun;27(6):965-72
pubmed: 22402647
J Clin Med. 2023 Mar 19;12(6):
pubmed: 36983379